ENO1 and neoplasm: With the unusual exposure of ENO1 on the surface of tumour cells, patients with solid tumours have been shown to develop autoantibodies to ENO1, the presence of which correlate with diagnosis of osteosarcoma [16] as well as tumours in the lung [9] and liver [17].